Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 4/2023

Content (24 Articles)

Treating a limb-threatening arterial clot in a newborn with catheter-directed thrombolysis

Grace Murray, Omri David Soffer, Rachel Taylor, Christopher Curzon, Chittalsinh Raulji

Risk adjusted venous thromboembolism prophylaxis following pancreatic surgery

Abigail Pohl, Aaron C. Spaulding, Emily R. Brennan, John Stauffer, Walid Akram Hussain, Divya Muraleedharan, Dorin T. Colibaseanu, Michael A. Edwards

Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis

Sophie Samuel, Wen Li, Koren Dunn, Jennifer Cortes, Thuy Nguyen, Daniel Moussa, Abhay Kumar, Thanh Dao, James Beeson, H Alex Choi, Louise D. McCullough

Effects of uridine and nucleotides on hemostasis parameters

Merve Arı, Engin Sağdilek, Evren Kılınç, Mehmet Cansev, Kasım Özlük

An exploratory study of effectiveness and safety of rivaroxaban in patients with left ventricular thrombus (R-DISSOLVE)

Qing Yang, Xin Quan, Yang Zhang, Guangxun Feng, Tao Zhang, Chuangshi Wang, Dongze Yu, Litian Yu, Yanmin Yang, Jun Zhu, Yan Liang

First use of large-bore suction thrombectomy for acute pulmonary embolism in Asia-Pacific: feasibility and short-term clinical outcomes

Pipin Kojodjojo, Hean Ann Ong, Poay Huan Loh, Edgar Tay, Peter Chang, Ivandito Kuntjoro, Ting Ting Low, Yinghao Lim

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

M. Berteotti, A. M. Gori, B. Giusti, A. Fortini, G. Grossi, N. Ciardetti, A. Migliorini, E. Lotti, R. Valenti, C. Di Mario, N. Marchionni, R. Marcucci

Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation

Deborah DeCamillo, Brian Haymart, Xiaowen Kong, Scott Kaatz, Mona A Ali, Geoffrey D Barnes

DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

Karlyn A Martin, Nicola Lancki, Celina Li, M. Elaine Eyster, Kristen Sanfilippo, Isabela A. Woller, Scott C. Woller, Lisa Baumann Kreuziger, Rachel P. Rosovsky

Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience

Ruben Mylvaganam, Romy Lawrence, Isaac Goldberg, Farbod Rahaghi, Stephen Chiu, S. Christopher Malaisrie, Daniel Schimmel, Ryan Avery, Karlyn Martin, Michael J. Cuttica

A scoping review of direct oral anticoagulant ambulatory management practices

Jasmine S. Mangrum, John A. Saunders, Nathorn Chaiyakunapruk, Daniel M. Witt, Jordan B. King

Direct oral anticoagulants in patients with venous thromboembolism and hematological malignancies

Renana Robinson, Galia Spectre, Michael Lishner, Ofek Sharabi, Eyal Robinson, Orly Hamburger Avnery, Anat Gafter-Gvili, Pia Raanani, Avi Leader

Recent trends in tranexamic acid use during postpartum hemorrhage in the United States

Ethan A. Litman, Phillip Ma, Seyedeh A. Miran, Stuart J. Nelson, Homa. K. Ahmadzia

Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis

Fátima Cereja, Mariana Alves, Joaquim J Ferreira, Daniel Caldeira

Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease

Gabriele Cortellini, Alberto Raiteri, Mattia Galli, Marzia Lotrionte, Fabio Piscaglia, Antonino Romano

Multiple Myeloma Letter to the Editor

Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib

Artur Saldanha, Maria Eduarda Veiga, Erica Okazaki, Cynthia Rothschild, Gracia Martinez, Vanderson Rocha, Fernanda A. Orsi, Paula Villaca

Obesity Correction

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

Karlyn A Martin, Nicola Lancki, Celina Li, M. Elaine Eyster, Kristen Sanfilippo, Isabela A. Woller, Scott C. Woller, Lisa Baumann Kreuziger, Rachel P. Rosovsky

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.